Moxibustion should be considered as an adjunctive therapy to improve lower urinary tract symptoms (LUTS) associated with benign prostate enlargement (BPE). Twenty-nine participants with BPE who were experiencing LUTS were randomly assigned to an integrative group (IG) or a conventional group (CG). The IG received moxibustion (twice weekly for four weeks at Sanyinjiao SP-6, Taichong LIV-3 and Guanyuan REN-4), along with conventional medication for four weeks, followed by conventional medication alone for eight weeks. The CG received conventional medication alone for 12 weeks. Prostate symptom scores were significantly improved in the IG compared with the CG at four weeks after baseline. Incomplete bladder emptying, straining to pass urine and nocturia also showed significant improvements in the IG. Moxibustion as an adjunct for lower urinary tract symptoms associated with benign prostate enlargement: A randomized controlled pilot trial. Medicine (Baltimore). 2020 Jan;99(4):e18918.

Sammanställd av Amaralis Kuhr, grupp 32